Home / Pharmacy & pharmaceuticals / PharmaTools.AI

PharmaTools.AI Ltd (United Kingdom)

PharmaTools.AI

Suite of AI tools for pharmaceutical communication and compliance: from patient-friendly package leaflet translation to automatic reference verification in pharmaceutical marketing material. Patiently AI is an MHRA-registered medical device (iOS/Android). Redacta enables safe use of ChatGPT/Claude through automatic de-identification.

Shared spot9of 16 professional tools with a GDPR profileOur summary of what the provider itself publishes about your data: whether the data is stored in the EU (2 points), whether there is a certification or GDPR guarantee (1), and whether the provider is established in the Netherlands or the EU (1). 3 or 4 points is Strong, 2 Good, 1 Limited, 0 Unknown. How we measure in pharmacy & pharmaceuticals
GDPR: Limited
  • Provider based outside the EU
  • Publishes certification/GDPR safeguards

Each tile is a professional tool in pharmacy & pharmaceuticals, with the strongest GDPR profile on the left. 6 professional tools, like PharmaTools.AI, have a limited GDPR profile: they share this spot. Click for that tool.

Priceon request (per tool or suite)on request (per tool or suite); Patiently AI available as an app
Free trialNot foundNot found on the provider's site when checked on 24 August 2026
Based inUnited KingdomOutside EU
ModelNot publicmultiple underlying models (not fully public); Redacta de-identifies patient data before AI processing; MHRA Class I medical device (Patiently AI); GDPR attention required for EU use

Last checked: 24 August 2026 · How we check

Is this your tool? Fill in missing details

What it does

Notes translated into patient language in 18 languages
Verification of claims and sources (RefCheckr)
Checking claims against pharmacodes (MedCheckr)
De-identification of patient data (Redacta)
PubMed access via MCP (PubCrawl)
Open-source verification framework OpenGATE
Consulting on AI compliance in pharmaceuticals
iOS, Android and web version available

Comparable in pharmacy & pharmaceuticals

All 16 professional tools for pharmacy & pharmaceuticals

PharmaTools.AI compared

Underlying model

multiple underlying models (not fully public); Redacta de-identifies patient data before AI processing; MHRA Class I medical device (Patiently AI); GDPR attention required for EU use. Many tools build on a large model from, for example, OpenAI or Anthropic. If in doubt, ask for the data processing agreement: it states where your data goes.

GDPR check for pharmacy & pharmaceuticals

Questions about PharmaTools.AI

Which AI model does PharmaTools.AI use?
The maker of PharmaTools.AI does not publish which AI model sits underneath. Several underlying models (not fully public); Redacta de-identifies patient data before AI processing; MHRA Class I medical device (Patiently AI); GDPR attention required for EU use.
How much does PharmaTools.AI cost?
on request (per tool or suite); Patiently AI available as an app. Check the current price on the provider's website; rates change often.
Who is PharmaTools.AI for?
PharmaTools.AI is aimed at pharmacy & pharmaceuticals. It supports tasks such as carrying out medication reviews and interaction checks, automating prescription processing and dispensing, and patient communication and medication guidance.
What should I look out for with AI in pharmacy & pharmaceuticals?
Medication data is special category personal data under the GDPR. Only use systems with a data processing agreement and EU hosting; do not store audio recordings of pharmaceutical consultations unencrypted on external servers. AI-supported medication reviews and interaction checks are supportive only: the pharmacist remains ultimately responsible for pharmaceutical care and must never rely blindly on algorithmic outcomes.

Every Friday: what changed in AI for pharmacy & pharmaceuticals

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.